3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Tobacco Use Disorder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashby, CR; Daley, LA; Gauthier, AG; Kennedy, TP; Lin, M; Mantell, LL; Wu, J | 1 |
1 review(s) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Tobacco Use Disorder
| Article | Year |
|---|---|
From nicotine to the cholinergic anti-inflammatory reflex - Can nicotine alleviate the dysregulated inflammation in COVID-19?
Topics: alpha7 Nicotinic Acetylcholine Receptor; Antibodies, Monoclonal, Humanized; Benzylidene Compounds; Cholinergic Agents; Cigarette Smoking; COVID-19 Drug Treatment; Dexamethasone; HMGB1 Protein; Humans; Inflammation; Nicotine; Pandemics; Pyridines; SARS-CoV-2; Tobacco Use Disorder | 2021 |